NRC vs SRTA

NRC exhibits a severe disconnect between its current market price ($17.04) and its deterministic value markers, with a Graham Number of $2.64 and an Intrinsic Value of $3.50. While the Piotroski F-Score of 6/9 suggests stable operational health, this is overshadowed by critical solvency risks including a Debt/Equity ratio of 5.74 and a Current Ratio of 0.55. Fundamental growth is in sharp decline, with YoY earnings crashing by 74.40%, and the dividend is unsustainable with a payout ratio of 104%. The recent 1-year price surge appears speculative as it contradicts the bearish technical trend and deteriorating fundamentals.

SRTA exhibits a critical fundamental disconnect, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration across all financial health dimensions. While the company shows impressive top-line revenue growth (83.5% YoY) and maintains a strong liquidity position (Current Ratio 6.38), it remains operationally unprofitable with a negative operating margin of -5.34%. The combination of consistent earnings misses, bearish insider selling, and a total failure in deterministic health scoring outweighs the optimistic analyst target price.